 |
|
New test proves effective in more cancers
October 07, 2005Avantogen Limited (ACU:ASX) today announced that cancer researchers at Perth's Telethon Institute for Child Health Research (TICHR) and Avantogen Limited have achieved an important milestone towards more individually targeted and effective treatments for cancer patients.
The research team has now identified crucial genes in a range of common cancers that have been reported to predict a patient's response to treatment. This follows the team's earlier success in studying a tumor suppressor gene associated with acute lymphoblastic leukaemia (ALL) in children.
By using a simple test developed at the Institute, they can rapidly detect the presence or absence of these tumor suppressor genes in the patient's cancer cells. Tumor suppressor genes are linked to a variety of cancers including lung, breast, renal, colorectal, pancreatic, gastric, lymphoma and malignant melanoma.
Professor Ursula Kees, who heads the Children's Leukaemia and Cancer Research Division at TICHR, said progress over the past 18 months has been excellent.
"The absence of specific tumor suppressor genes in tumor specimens provides a valuable genetic marker to help us determine who is at greater risk of relapse," she said.
"We've now used this new rapid test in a cancer that occurs in adults and found it to be effective in providing important information about the genetic makeup of the tumor-information that doctors could use at an early stage to decide on the most effective treatment regimen for that individual patient."
Dr Leonard Firestone, CEO and managing director of Avantogen, said his company is currently considering the most appropriate commercial model to bring the test to the market. The new test is based on fast and simple procedures that can be run out of most diagnostic laboratories.
Director of the Telethon Institute for Child Health Research, Professor Fiona Stanley, said the Institute was delighted to partner with Avantogen on this development because of their strong credentials in the oncology field.
Research Australia
Professor Ursula Kees, who heads the Children's Leukaemia and Cancer Research Division at TICHR, said progress over the past 18 months has been excellent.
"The absence of specific tumor suppressor genes in tumor specimens provides a valuable genetic marker to help us determine who is at greater risk of relapse," she said.
"We've now used this new rapid test in a cancer that occurs in adults and found it to be effective in providing important information about the genetic makeup of the tumor-information that doctors could use at an early stage to decide on the most effective treatment regimen for that individual patient."
Dr Leonard Firestone, CEO and managing director of Avantogen, said his company is currently considering the most appropriate commercial model to bring the test to the market. The new test is based on fast and simple procedures that can be run out of most diagnostic laboratories.
Director of the Telethon Institute for Child Health Research, Professor Fiona Stanley, said the Institute was delighted to partner with Avantogen on this development because of their strong credentials in the oncology field.
Research Australia
New DNA Test Uses Nanotechnology to Find Early Signs of Cancer
Using tiny crystals called quantum dots, Johns Hopkins researchers have developed a highly sensitive test to look for DNA attachments that often are early warning signs of cancer.
Nature press release for 7 February issue
[415603] EARTH: PACIFIC CIRCULATION HAS SLOWED (pp603-608) The wind-driven circulation of waters in the Pacific Ocean has been slowing since the 1970s, according to a new analysis published in this week`s Nature. This could have something to do with the concomitant rise in El Ni'±o events, and may mean that less carbon has reached the ocean surface over the past decade. Across the width of the Pacific, water circulates in two giant loops, one in each of the Northern and Southern hemispheres. The water flows from the subtropics to the tropics at depths of about 50–400 metres, rises to the surface near the Equator and heads back towards the poles at the surface. This circulation has ch
More Cancer Test Current Events and Cancer Test News Articles
 |
What Your Doctor May Not Tell You About(TM) Colorectal Cancer: New Tests, New Treatments, New Hope (What Your Doctor May Not Tell You About...) by Mark Bennett Pochapin (Author) - What Your Doctor May Not Tell You About Colorectal Cancer was published in Warner hardcover (0-446-53188-X) in 3/04. The book features a foreword by Katie Couric. - Dr. Pochapin made an appearance on the Today show in conjunction with the hardcover publication of this book. Previously, he had been chosen by Katie Couric to be the Medical Director of the Jay Monahan Center for Gastrointestinal Health, named in honor of Ms. Couric's late husband. - The author is an associate professor of clinical medicine at the Weill Medical College of Cornell University and Chief of Gastrointestinal Endoscopy at New York Presbyterian Hospital's Weill Cornell Medical Center. - There are approximately 100,000 new colorectal cancer cases diagnosed annually, making it the second leading cause of... |
 |
philosophy purity made simple, one-step facial cleanser 8 fl oz (236.6 ml) by philosophy philosophy®: purity is natural. we come into this world with all the right instincts. we are innocent, and therefore perceive things as they should be, rather than how they are. our conscience is clear, our hands are clean, and the world at large is truly beautiful. one-step facial cleanser: deep cleans pores and eliminates makeup build-up contains mild cleansing agents natural oil extracts help condition skin contains a proprietary blend of extracts for a unique, fresh scent |
 |
First Check Home ColoCheck Home Test, Colorectal Disease, 1 Test (Pack of 2) by First Check A First Check at 50 product. No specimen handling. No diet restrictions. FDA cleared. Fast. Accurate. Simple. A home test for the early warning signs of Colorectal Disease. Results in minutes. Early detection is key. First Check ColoCheck provides informa |
 |
Winning the Battle Against Prostate Cancer Directed By: (c) Information Television Network |
 |
New Tests, Treatments: Better Outcome for Colorectal Cancer Colorectal cancer is the third most common cancer and the second leading cause of cancer mortality in the U.S. Advances in imaging, genetics, molecular diagnostics, surgical techniques and chemotherapy are now making significant gains in our ability to prevent, diagnose, and treat this serious disease. Dr. Fisher reviews some of these recent successes and shares a vision of future care based on current research. |
|
Reebok Women's Pink Ribbon Luna Hexride Avon Walk Around the World for Breast Cancer Shoes (06 US) by Reebok Synthetic and breathable mesh upper, compression molded EVA midsole. Hexride technology provides an air spring cushioned ride. White/Silver with Pink Ribbon. Reebok is a proud partner of the 2008 Avon Walk Around the World for Breast Cancer. | |
 |
Test Tubes Surrounding Doctor in Cancer Research Lab Photographic Poster Print by Fritz Goro, 24x18 by Art.com Art.com is the world's largest retailer of art prints, posters, photographs, and framed artwork. With our huge selection of over 400,000 prints, you'll easily find the perfect piece for your home, office, or classroom. Our art is printed on quality paper. When you order framed artwork, the piece is built by our team of in-house professionals. Visit our Amazon store today at www.amazon.com/artdotcom to find Special Offers and search for products based on 'Artist Name' and 'Subject Categories' such as Movie, Music, Vintage, TV, Children, Travel, Kitchen, Museum Art, Animals, Floral, Motivational, and Sports. Art.com is dedicated to providing you with high quality products and service by offering you 100% satisfaction guaranteed. We ship internationally to over 80 countries. Decorate your... |
 |
K2 Endurance Sunblock SPF 50 4.0 oz by K2 Endurance Suncare K2 Endurance Sunblock's advanced, long lasting UVA + UVB protection, with antioxidents remove free radicals for cellular skin protection and invisible non-greasy formula contains moisturizers to help protect your skin from dry cold weather. SPF 50 Protection |
![Breast Cancer [Explicit]](http://ecx.images-amazon.com/images/I/61rxVYpavwL._SL160_.jpg) |
Breast Cancer [Explicit] Peter & The Test Tube Babies (Primary Contributor) |
 |
Mobile Edge Premium Tote Bag by MobileEdge The Premium Tote is the natural 'step up' from the Select. This bag is made from the same premium Microfiber, but has larger overall dimensions which increase its carrying capacity.The premise was simple enough - combine fashion with cutting-edge technology. Mobile Edge knows the importance of protecting your notebook computer - and the data that you have on it. That's why each model in this collection features the superior SafetyCell Computer Protection Sleeve.THE PREMIUM TOTE FEATURES:Superior SafetyCell computer protection compartment.Zippered interior pocket.Detachable cosmetics/accessory pouch.Stylish fittings and self-healing zippers.EZ-Access ticket pocket. |
| © 2009 BrightSurf.com |